Marksans Pharma Limited (BOM:524404)
India · Delayed Price · Currency is INR 325.30
+0.95 (0.29%)
At close: Oct 7, 2026
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 147.44 billion as of October 7, 2026. Its market cap has increased by 98.31% in one year.
Market Cap
147.44B
Enterprise Value
141.26B
Revenue
31.72B
Ranking
n/a
PE Ratio
28.45
Stock Price
325.30
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 147.44B, an increase of 3,937.64%. That is a compound annual growth rate of 20.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 147.44B | 80.46% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 207.20B |
| Caplin Point Laboratories | 197.91B |
| Jubilant Pharmova | 156.49B |
| AstraZeneca Pharma India | 147.83B |
| Viyash Scientific | 100.06B |
| Procter & Gamble Health | 88.00B |
| Morepen Laboratories | 74.14B |